Why the FDA should not approve an ineffective multicancer screening test
Researchers and analysts are focusing on multicancer blood tests as media outlets report on studies, availability, and regulatory debates.
13 trends tracked about this subject — the full history, oldest to newest below.
Researchers and analysts are focusing on multicancer blood tests as media outlets report on studies, availability, and regulatory debates.
Medical coverage highlights an overlooked symptom linked to colorectal cancer as a potential warning sign.
Grail's multi-cancer blood test nears landmark FDA approval, triggering a massive stock surge and questions over insurance coverage.
A multi-cancer early detection blood test draws investor enthusiasm and trial data coverage across major financial and health outlets.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Health outlets and regional news outlets highlight prostate cancer awareness, early screenings, and dietary recommendations.
Recent coverage highlights that many prostate cancers do not need immediate treatment, coinciding with Prostate Cancer Awareness Month.
Global health initiatives and medical experts are urging increased prostate cancer screenings to improve early detection and survival rates.
17 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical experts and news outlets are highlighting the critical need for early lung cancer screening to combat the disease's tendency to remain silent for years.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical experts are warning men about overlooked early symptoms of prostate cancer to improve detection rates and patient outcomes.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.